≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Colitis, primary sclerosing

DOID Endpoint Browser

K11_PSC_COLITIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • K11_CHOLANGI
2381

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

506

6. Filter based on genotype QC (FinnGen only)

506

Control definitions (FinnGen only)

Control conditions
not K11_CHOLANGI

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF3

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 506 232 274
Unadjusted period prevalence (%) 0.10 0.08 0.12
Median age at first event (years) 30.23 30.27 30.19

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
469
Matched controls
4691
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K83.0
ICD-10 Finland
Cholangitis
4503599627370496.0
323.0
466
*
A05AA02
ATC
ursodeoxycholic acid; oral
1493.0
323.0
383
14
A07EC02
ATC
mesalazine; oral, rectal
290.5
323.0
423
144
K51.5
ICD-10 Finland
Left sided colitis
288.5
323.0
359
52
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
386.0
323.0
430
130
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
953.7
323.0
305
9
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
139.5
314.5
319
70
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
46.2
249.9
332
233
UJF32
NOMESCO Finland
Coloscopy
31.0
219.4
380
567
UJF30
NOMESCO Finland
Ileoscopy through colon
37.6
213.2
291
195
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
375.7
178.1
169
7
UJK02
NOMESCO Finland
ERCP
207.7
174.4
172
13
K51.8
ICD-10 Finland
Other ulcerative colitis
93.6
156.7
169
28
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
93.6
153.0
165
27
L04AX01
ATC
azathioprine; systemic
33.5
152.6
206
107
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
25.6
149.1
222
159
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
167.1
147.4
149
13
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
61.8
141.1
163
40
WX404
NOMESCO Finland
Intravenous generell anesthesy
11.8
118.9
272
490
A07EA06
ATC
budesonide; oral, local oral
29.6
117.2
162
82
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
61.2
106.3
123
27
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
216.5
101.9
102
6
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
73.1
99.7
112
20
WX402
NOMESCO Finland
General anaesthesia
9.2
93.1
240
480
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
83.2
89.7
99
15
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
7.8
88.9
277
730
UJK12
NOMESCO Finland
Peroral cholangioscopy
1017.9
88.7
84
*
P01AB01
ATC
metronidazole; oral, rectal
6.9
82.0
324
1142
K50.8
ICD-10 Finland
Other Crohn disease
41.3
76.8
96
29
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
31.4
71.8
96
38
H02AB06
ATC
prednisolone; systemic
6.0
70.6
326
1291
K83.1
ICD-10 Finland
Obstruction of bile duct
143.7
70.1
73
6
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
136.7
66.9
70
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.1
65.2
231
645
A07EA02
ATC
hydrocortisone; rectal
24.5
62.7
90
45
K50.1
ICD-10 Finland
Crohn disease of large intestine
34.7
62.3
81
28
J01MA12
ATC
levofloxacin; systemic
6.9
62.1
184
402
K50.9
ICD-10 Finland
Crohn disease, unspecified
27.4
60.6
84
37
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
123.2
60.5
64
6
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.3
59.0
163
319
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
+∞
57.5
54
*
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
+∞
55.3
52
*
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
158.5
54.1
56
*
ZX120
NOMESCO Finland
Intravenous
8.7
50.0
117
173
WX002
NOMESCO Finland
Sedation and analgesia
5.7
50.0
171
429
TPH04
NOMESCO Finland
Cathetrisation of vein
5.4
49.0
179
483
J01MA02
ATC
ciprofloxacin; systemic
4.4
48.9
253
977
Z94.4
ICD-10 Finland
Liver transplant status
139.5
47.8
50
*
K76.9
ICD-10 Finland
Liver disease, unspecified
45.1
45.9
56
14
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
133.3
45.7
48
*
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
248.2
44.8
45
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
130.3
44.6
47
*
H02AB07
ATC
prednisone; oral
6.0
44.2
138
303
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
+∞
43.4
41
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
124.1
42.5
45
*
K51
ICD-10 Finland
Ulcerative colitis
40.7
41.0
51
14
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
8.2
40.9
98
147
A07EC01
ATC
sulfasalazine; oral, rectal
7.5
40.0
102
168
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.2
39.8
82
95
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
94.5
39.5
43
5
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
115.1
39.4
42
*
K74.3
ICD-10 Finland
Primary biliary cirrhosis
56.5
39.3
46
9
K50.0
ICD-10 Finland
Crohn disease of small intestine
20.1
37.7
57
32
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
397.3
37.6
37
*
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
38.1
35.7
45
13
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
82.6
34.4
38
5
L01BB02
ATC
mercaptopurine; oral
27.3
34.3
47
19
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
188.6
34.2
35
*
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
41.7
34.0
42
11
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.8
33.2
102
213
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.9
33.1
65
68
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
32.7
31
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
177.0
32.1
33
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
75.3
31.3
35
5
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
30.5
29
*
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
19.5
30.3
46
26
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
17.6
28.7
45
28
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
13.2
28.2
50
42
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
82.9
28.1
31
*
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
154.2
28.0
29
*
127
Kela drug reimbursment
Transplant complication
13.3
26.7
47
39
JN4CD
NOMESCO Finland
Very extensive body CT
10.9
26.2
51
52
L04AD01
ATC
ciclosporin; systemic
13.3
26.1
46
38
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
21.7
26.1
38
19
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
47.2
25.8
31
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
25.7
226
1133
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
8.7
25.3
56
72
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
+∞
25.2
24
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
4.5
25.2
99
265
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
25.1
25.2
35
15
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
71.4
24.1
27
*
A07EA01
ATC
prednisolone; rectal
38.5
23.3
29
8
JJ5AT
NOMESCO Finland
NA
126.2
22.8
24
*
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
16.1
22.4
36
24
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
22.3
213
1096
H02AB04
ATC
methylprednisolone; systemic
3.9
22.2
101
308
JN3AD
NOMESCO Finland
Abdominal CT examination
5.8
21.9
65
127
R50.9
ICD-10 Finland
Fever, unspecified
3.7
21.9
107
346
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
21.7
167
750
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.9
21.5
63
121
D94
ICPC
Chronic enteritis/ulcerative colitis
31.7
20.8
27
9
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.8
20.6
53
86
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
13.9
20.5
35
27
UJF92
NOMESCO Finland
Capsular endoscopy
10.8
20.3
39
39
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
28.5
20.3
27
10
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
60.3
20.1
23
*
L04AA06
ATC
mycophenolic acid; systemic
10.5
20.0
39
40
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
7.6
19.4
46
66
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
48.2
19.4
23
5
3AC01
NOMESCO Finland
NA
19.2
19.3
29
16
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
197.6
18.7
19
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
7.5
18.4
44
64
N02AX02
ATC
tramadol; systemic, rectal
2.5
18.4
209
1149
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
12.2
18.3
33
29
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
54.8
18.1
21
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
14.5
18.0
30
22
WX419
NOMESCO Finland
Other general anesthesy
15.4
17.9
29
20
C10AC01
ATC
colestyramine; oral
8.2
17.8
40
53
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
19.6
17.5
26
14
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
14.6
17.5
29
21
UJF02
NOMESCO Finland
Peroral enteroscopy
65.8
16.9
19
*
L04AB04
ATC
adalimumab; parenteral
8.8
16.8
36
44
WVA20
NOMESCO Finland
Medicine administration
11.4
16.7
31
29
K85.8
ICD-10 Finland
Other acute pancreatitis
24.1
16.6
23
10
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
16.4
102
387
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.5
16.2
33
37
L04AA01
ATC
[U] ciclosporin; systemic
14.2
16.2
27
20
K85
ICD-10 Finland
Acute pancreatitis
19.4
16.2
24
13
1370
FHL
Colonoscopy, whole colon
62.2
15.9
18
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
62.2
15.9
18
*
L04AC05
ATC
ustekinumab; parenteral
34.7
15.9
20
6
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
6.4
15.9
42
71
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
27.4
15.7
21
8
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
27.4
15.7
21
8
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
+∞
15.7
15
*
Z93.2
ICD-10 Finland
Ileostomy status
39.5
15.5
19
5
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
82.8
14.7
16
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
14.5
112
487
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
9.1
14.5
30
35
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
23.1
14.3
20
9
R4110
NOMESCO Finland
Physiotherapy
2.4
14.0
140
700
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
20.8
13.9
20
10
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.9
13.6
57
159
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
+∞
13.6
13
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
35.2
13.6
17
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
13.1
59
176
TPH07
NOMESCO Finland
Cathetrisation of artery
3.9
13.0
55
155
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
8.9
12.9
27
32
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.0
12.6
40
85
K83
ICD-10 Finland
Other diseases of biliary tract
+∞
12.6
12
*
A07DA03
ATC
loperamide; oral
6.8
12.5
31
48
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
20.7
12.5
18
9
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.4
12.4
62
201
UJD02
NOMESCO Finland
Gastroscopy
6.4
12.3
32
53
A02BC02
ATC
pantoprazole; systemic
2.0
12.1
284
2029
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.1
11.9
47
125
WX004
NOMESCO Finland
Patient-controlled sedation
30.9
11.7
15
5
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
+∞
11.5
11
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
11.5
11
*
TK800
NOMESCO Finland
Hemodialysis
7.3
11.5
27
39
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
11.4
167
981
JFF10
NOMESCO Finland
Loop enterostomy
36.0
11.3
14
*
K92.1
ICD-10 Finland
Melaena
4.9
10.9
35
76
A02BC01
ATC
omeprazole; systemic
2.2
10.8
124
652
4AA12
NOMESCO Finland
NA
22.1
10.7
15
7
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
61.4
10.7
12
*
H02AB09
ATC
hydrocortisone; systemic
5.9
10.6
29
52
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
10.5
67
254
K75.4
ICD-10 Finland
Autoimmune hepatitis
112.4
10.5
11
*
K83.3
ICD-10 Finland
Fistula of bile duct
112.4
10.5
11
*
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
112.4
10.5
11
*
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
16.5
10.4
16
10
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.0
10.4
41
109
B01AB05
ATC
enoxaparin; parenteral
2.2
10.3
123
656
JAH00
NOMESCO Finland
Laparotomy
6.7
10.2
25
39
XX3DW
NOMESCO Finland
Time consuming IT work
3.2
10.0
53
179
JFH10
NOMESCO Finland
Total colectomy and ileostomy
41.0
10.0
12
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
11.0
9.9
18
17
JKA20
NOMESCO Finland
Cholecystectomy
8.1
9.7
21
27
A07AA09
ATC
vancomycin; oral
11.7
9.6
17
15
D99
ICPC
Disease digestive system other
18.0
9.5
14
8
JFF13
NOMESCO Finland
Terminal enterostomy
102.0
9.4
10
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
30.7
9.4
12
*
JL5BM
NOMESCO Finland
Bile and pancreas ducts MRI examination with 3 Tesla magnet
+∞
9.4
9
*
JJC60
NOMESCO Finland
Total excision of transplanted liver
+∞
9.4
9
*
JJA20
NOMESCO Finland
Open biopsy of liver
37.5
9.1
11
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
9.0
97
490
A07AA11
ATC
rifaximin; oral
24.6
8.9
12
5
WX892
NOMESCO Finland
Monitored bed care
3.4
8.9
43
136
R94.5
ICD-10 Finland
Abnormal results of liver function studies
11.0
8.8
16
15
253
Kela drug reimbursment
NA
51.0
8.7
10
*
3042
Kela drug reimbursment
NA
51.0
8.7
10
*
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
51.0
8.7
10
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
11.9
8.6
15
13
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
10.3
8.6
16
16
UJG02
NOMESCO Finland
Proctoscopy
7.6
8.5
19
26
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
28.1
8.5
11
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.4
8.4
21
34
4AA33
NOMESCO Finland
NA
+∞
8.4
8
*
K83.4
ICD-10 Finland
Spasm of sphincter of Oddi
+∞
8.4
8
*
5761A
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]
+∞
8.4
8
*
56399
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Other
+∞
8.4
8
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
8.3
102
548
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.2
8.2
30
75
WW500
NOMESCO Finland
Blood transfusion
5.0
8.2
25
52
TJF80
NOMESCO Finland
Ostomy education
12.0
8.1
14
12
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
34.0
8.1
10
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
34.0
8.1
10
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
4.9
8.1
25
53
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.2
7.8
40
133
JN4BD
NOMESCO Finland
Extensive body CT
2.8
7.8
50
193
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.7
7.8
53
212
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
7.6
7.7
17
23
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
7.7
44
157
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.6
7.6
25
57
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.6
7.5
18
28
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
81.3
7.4
8
*
1280
FHL
Endoscopic retrograde cholangiography and pancreaticography
81.3
7.4
8
*
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
81.3
7.4
8
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
81.3
7.4
8
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
81.3
7.4
8
*
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
+∞
7.3
7
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
+∞
7.3
7
*
K83.2
ICD-10 Finland
Perforation of bile duct
+∞
7.3
7
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
7.3
7
*
M81.8
ICD-10 Finland
Other osteoporosis
30.5
7.2
9
*
D97
ICPC
Liver disease NOS
30.5
7.2
9
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
20.4
7.2
10
5
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
12.3
7.1
12
10
4AB02
NOMESCO Finland
NA
12.3
7.1
12
10
N02AA05
ATC
oxycodone; systemic
2.5
7.0
54
229
R4190
NOMESCO Finland
Nutritional therapy
3.5
7.0
31
93
JN4AD
NOMESCO Finland
Body CT examination
3.0
6.9
39
137
130
Kela drug reimbursment
Malignant tumour
3.2
6.9
35
117
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
40.7
6.8
8
*
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
17.0
6.8
10
6
A04AA02
ATC
granisetron; systemic, transdermal
3.6
6.7
29
85
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.3
6.7
23
55
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.3
6.7
19
37
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.0
6.7
25
65
WZC30
NOMESCO Finland
Teaching
2.3
6.6
60
279
C03DA01
ATC
spironolactone; oral
2.8
6.6
40
150
E86
ICD-10 Finland
Volume depletion
7.0
6.6
15
22
B99
ICD-10 Finland
Other and unspecified infectious diseases
7.0
6.6
15
22
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
6.5
70
354
L04AA10
ATC
sirolimus; oral
70.8
6.4
7
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
70.8
6.4
7
*
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
70.8
6.4
7
*
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
70.8
6.4
7
*
K90.0
ICD-10 Finland
Coeliac disease
4.1
6.4
23
58
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.6
6.3
27
79
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
11.2
6.3
11
10
K56.7
ICD-10 Finland
Ileus, unspecified
9.4
6.3
12
13
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.4
6.3
12
13
JF1BD
NOMESCO Finland
Very extensive small bowel CT
18.3
6.3
9
5
J01DB01
ATC
cefalexin; oral
1.8
6.3
367
3154
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
+∞
6.3
6
*
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
+∞
6.3
6
*
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
+∞
6.3
6
*
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
27.1
6.2
8
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
6.2
72
375
B01AB04
ATC
dalteparin; parenteral
4.1
6.2
22
55
JFB00
NOMESCO Finland
Partial resection of small intestine
8.8
6.1
12
14
Z51.5
ICD-10 Finland
Palliative care
3.9
6.1
23
61
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
6.2
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
363
438
26.79
323.31
3.5
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
285
76
84.57
307.65
3.1
1.6
g/l
0.9
0.8
0.21
264
58
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
205
35
97.78
307.65
1.8
1.1
titre
158.5
—
—
13
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
410
297
68.49
307.65
8.3
4.4
ug/l
2.5
21.1
0.69
329
239
(3048689) Calprotectin [Mass/mass] in Stool
424
599
38.51
307.65
7.3
2.5
ug/g
192.4
120.2
3.99
403
478
(3005719) IgG [Mass/volume] in Serum or Plasma
349
314
33.60
307.65
4.4
2.4
g/l
12.8
10.2
19.31
337
292
(3028026) IgM [Mass/volume] in Serum or Plasma
325
258
33.42
307.65
3.4
1.5
g/l
1.3
1.3
0.06
317
242
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
278
44
139.00
307.65
2.8
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
367
106
123.40
307.65
7.6
2.9
u/ml
44.7
1552.8
0.58
343
88
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
198
20
162.00
307.65
1.9
1.3
umol/l
11.1
10.4
0.34
198
20
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
267
146
37.60
307.65
2.7
1.6
titre
363.3
173.3
—
6
6
(3007566) Smooth muscle Ab [Titer] in Serum
322
126
68.53
307.65
3.0
1.1
titre
66.4
80.8
0.25
33
12
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
205
35
97.78
307.65
1.8
1.1
titre
346.8
98.0
—
85
5
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
290
26
259.95
307.65
2.7
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
309
375
19.60
267.36
6.2
2.1
u/l
40.7
162.9
0.47
303
317
(40768441) Liver Pathology biopsy report
143
25
79.34
262.67
2.3
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
341
576
16.09
228.43
3.0
1.3
titre
477.3
401.1
0.36
134
114
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
305
449
15.58
226.02
11.5
2.1
umol/l
9.0
8.3
0.18
292
389
(3033658) Prothrombin time (PT) actual/Normal
397
966
15.44
191.26
17.3
3.8
%
95.9
93.3
1.26
391
948
(3032080) INR in Blood by Coagulation assay
446
1293
21.66
183.08
18.4
6.3
inr
1.1
1.2
3.55
144
400
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
446
1436
18.76
160.36
16.3
3.0
u/l
37.9
32.7
3.33
437
1377
(3042936) Bacteria identified in Isolate by Culture
269
524
9.83
150.57
2.8
2.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
337
913
9.06
136.13
3.5
1.4
g/l
2.5
2.2
2.78
322
576
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
177
234
11.10
135.12
2.6
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
401
1306
10.98
135.10
14.5
6.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
231
430
9.04
132.48
3.1
2.3
%
22.3
23.9
0.71
212
381
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
117
85
17.60
131.48
6.5
4.3
iu/ml
863.7
497.8
0.39
27
11
(3004789) Transferrin [Mass/volume] in Serum or Plasma
228
467
8.07
118.10
3.1
2.2
g/l
2.4
2.4
0.25
218
437
(3022948) Iron [Moles/volume] in Serum or Plasma
234
511
7.66
113.35
3.1
2.2
umol/l
12.6
13.9
1.55
226
474
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
96
63
18.57
113.19
1.2
1.0
g/l
1.6
1.4
2.78
90
58
(3006922) Hepatitis E virus Ab [Presence] in Serum
70
24
33.69
107.08
1.1
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
437
1828
11.20
105.44
17.6
6.2
%
0.7
0.7
1.62
431
1734
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
68
24
32.58
102.99
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
68
24
32.58
102.99
1.1
1.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
439
1885
11.04
101.65
17.6
6.1
%
2.9
2.9
0.12
433
1785
(3019069) Monocytes/100 leukocytes in Blood
440
1898
11.11
101.24
17.9
6.4
%
9.1
8.5
3.69
434
1812
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
60
15
45.25
99.99
4.8
2.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
447
2003
11.56
97.35
17.8
6.2
e9/l
0.0
0.0
0.65
433
1772
(3001604) Monocytes [#/volume] in Blood
446
1995
11.42
97.27
17.8
6.2
e9/l
0.6
0.6
0.23
432
1764
(3044640) Blood type and Crossmatch panel - Blood
335
1158
6.60
96.44
4.2
2.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
453
2073
12.32
96.01
18.0
6.6
e9/l
0.2
0.2
0.06
437
1854
(3002030) Lymphocytes/100 leukocytes in Blood
440
1975
10.41
94.39
17.8
6.0
%
29.4
29.0
0.36
435
1882
(3018010) Neutrophils/100 leukocytes in Blood
434
1948
9.63
92.17
17.4
5.9
%
55.7
56.5
0.77
429
1861
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
268
795
6.04
90.60
4.8
2.1
mg/l
3.2
3.0
0.70
246
687
(3019198) Lymphocytes [#/volume] in Blood
446
2080
10.65
90.15
18.0
6.1
e9/l
1.8
1.9
2.60
432
1869
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
395
1650
7.35
89.78
11.5
7.0
mmol/l
1.2
1.2
0.44
350
1434
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
100
108
11.29
86.63
1.4
1.3
u/ml
397.7
177.3
3.46
53
59
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
102
115
10.86
85.64
1.4
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
322
1165
5.85
85.09
6.5
2.4
u/l
70.2
56.7
1.61
312
1095
(3018418) pH of Serum or Plasma
291
969
5.71
84.84
6.3
3.7
ph
7.4
7.4
1.78
63
169
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
72
51
16.29
80.86
1.4
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
363
1508
5.98
79.69
10.3
6.3
mmol/l
1.2
1.2
0.17
351
1394
(3023183) Ammonium ion [Moles/volume] in Plasma
82
76
12.68
78.52
7.9
3.1
umol/l
34.9
36.4
0.19
74
62
(3013650) Neutrophils [#/volume] in Blood by Automated count
455
2341
10.36
77.14
22.6
9.4
e9/l
3.6
4.0
5.32
443
2060
(3042733) HLA Ab [Presence] in Serum
46
12
42.07
75.45
1.2
4.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
55
26
23.61
74.50
3.5
1.4
g/l
0.8
1.1
1.76
55
26
(3016650) Hepatitis A virus Ab [Presence] in Serum
77
72
12.43
73.17
1.2
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
84
95
10.40
69.89
1.3
1.4
u/ml
127.3
91.5
—
10
14
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
86
101
10.05
69.57
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
215
642
5.08
68.96
1.7
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
379
1790
5.45
66.59
25.3
8.7
e9/l
0.0
0.0
0.43
354
1474
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
96
138
8.35
65.92
1.8
1.7
iu/ml
0.0
0.2
0.70
31
24
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
56
36
17.37
65.86
1.3
1.3
u/l
53.1
53.2
0.01
42
23
(40768804) Tissue Pathology biopsy report
340
1486
4.93
65.80
3.7
1.9
—
—
—
0
0
(4035726)
138
291
6.15
65.72
1.8
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
39
12
35.13
60.94
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
39
12
35.13
60.94
1.0
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
241
852
4.49
60.90
8.7
4.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
475
2844
11.94
59.85
11.8
3.7
mm/h
15.5
9.5
12.83
465
2634
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
237
842
4.41
59.18
1.9
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
67
70
10.88
58.74
1.2
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
109
205
6.50
58.00
1.4
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
259
1001
4.25
57.16
14.7
7.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
104
190
6.63
56.92
1.4
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
349
1718
4.32
53.44
4.7
2.7
ug/l
109.6
113.0
0.10
340
1606
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
236
889
4.10
53.25
3.9
2.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
54
50
11.97
51.23
1.4
1.2
g/l
0.5
0.3
2.10
34
36
(4062490)
54
50
11.97
51.23
1.4
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
54
50
11.97
51.23
1.4
1.2
g/l
3.4
2.4
2.76
34
36
(3027135) IgG subclass 1 [Mass/volume] in Serum
54
50
11.97
51.23
1.4
1.2
g/l
9.5
6.2
3.52
35
36
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
48
38
13.85
50.14
1.1
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
40
23
18.80
49.39
2.0
1.4
u/l
4.2
3.6
—
25
8
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
58
66
9.80
47.58
2.8
3.9
u/ml
1393.7
3061.1
—
6
9
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
123
306
4.99
47.53
3.3
2.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
344
1774
3.93
46.89
6.4
3.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
30
11
28.93
44.13
1.1
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
30
11
28.93
44.13
1.1
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
467
3075
7.73
43.84
16.6
3.0
u/l
120.8
43.6
21.72
460
2941
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
48
47
11.18
43.75
1.2
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
29
10
30.70
43.49
3.5
3.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
169
572
3.93
43.08
6.4
3.8
mmol/l
0.8
0.8
5.36
163
543
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
48
50
10.50
41.88
2.5
2.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
112
293
4.62
40.25
5.3
4.6
%
0.3
0.4
0.79
32
72
(3021879) Hepatitis B virus core Ab [Presence] in Serum
135
408
4.15
40.09
1.4
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
116
317
4.45
39.37
6.0
4.7
%
0.4
0.9
1.67
43
97
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
59
87
7.54
39.02
1.6
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
108
281
4.61
39.01
6.0
5.0
%
0.0
0.0
0.74
33
73
(3002032) Base excess in Venous blood by calculation
112
314
4.30
36.58
6.4
4.7
mmol/l
0.4
1.8
3.23
98
250
(3021440) Promyelocytes/100 leukocytes in Blood
108
297
4.35
36.16
6.3
4.9
%
0.0
0.1
1.50
41
85
(3034274) Bile acid [Moles/volume] in Serum --fasting
52
75
7.61
34.99
2.7
2.3
umol/l
33.0
5.2
3.18
46
56
(40768797) Stomach Pathology biopsy report
146
513
3.59
34.32
1.6
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
31
22
14.95
34.20
3.2
5.5
mg/l
7.8
8.6
0.19
25
22
(3000991) Gas panel - Venous blood
106
301
4.19
33.87
16.4
9.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
111
326
4.08
33.87
4.0
3.4
%
1.9
1.8
0.33
105
302
(3002582) Erythrocytes [#/volume] in Urine
229
1079
3.05
32.72
4.1
2.8
e6/l
182.3
47.0
0.39
192
826
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
62
119
5.80
31.62
1.3
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
147
546
3.39
31.37
3.1
2.7
e6/l
2.0
2.2
0.14
97
291
(3030467) Casts [#/volume] in Urine by Automated count
212
980
3.00
31.01
4.2
2.8
e6/l
0.3
0.3
0.04
177
732
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
87
228
4.40
30.77
5.1
3.2
mmol/l
1.2
1.2
1.11
82
205
(3018095) Leukocytes [#/volume] in Urine
252
1290
2.90
30.37
4.7
3.3
e6/l
38.6
81.6
0.56
198
880
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
172
723
3.09
29.58
2.4
1.9
%
1.5
1.4
0.21
154
668
(3023520) Reticulocytes [#/volume] in Blood
84
223
4.32
29.15
2.7
3.3
e9/l
77.7
76.4
0.07
59
163
(3026782) Osmolality of Urine
164
678
3.10
28.96
3.2
2.4
mosm/kgh2o
544.1
561.9
0.43
152
584
(3044889) 12 lead EKG panel
398
2647
3.36
28.90
3.9
3.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
204
957
2.90
28.59
4.2
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
247
1293
2.78
27.90
2.4
1.8
pmol/l
95.3
96.4
0.15
157
676
(3000850) Epithelial cells [#/volume] in Urine
168
720
3.00
27.65
3.2
2.3
e6/l
6.3
6.1
0.05
157
631
(3025941) Bacteria identified in Stool by Culture
85
241
4.04
26.91
1.7
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
43
68
6.82
26.50
5.3
3.6
%
53.1
55.7
0.44
43
68
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
34
41
8.82
26.42
1.1
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
239
1261
2.70
26.15
4.2
2.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
143
579
3.05
25.83
3.2
2.5
e6/l
0.9
1.2
0.50
95
324
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
90
277
3.74
25.28
3.0
2.5
ml/min/173m2
66.4
74.9
0.71
38
114
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
65
158
4.57
25.13
17.4
15.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
196
962
2.69
24.44
10.1
4.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
52
112
5.06
23.21
1.8
2.2
g/l
1.3
1.5
1.15
45
101
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
131
534
2.96
23.12
2.5
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
155
697
2.76
22.72
1.9
1.4
nmol/l
19.1
20.8
0.81
150
602
(44816559) Phosphatidylethanol [Mass/volume] in Blood
53
124
4.66
21.41
1.5
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
38
68
5.96
20.70
5.6
3.3
e9/l
4.0
3.9
0.03
38
68
(3014148) Varicella zoster virus Ab [Titer] in Serum
37
65
6.06
20.53
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
112
449
2.92
20.14
1.5
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
203
1096
2.42
19.87
1.9
2.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
457
3590
3.82
19.74
50.2
14.1
%
13.8
13.4
5.96
457
3529
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
81
5.28
19.09
3.0
4.9
u/ml
0.2
0.3
2.62
19
45
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
494
4134
9.22
18.90
48.7
11.3
mg/l
16.6
21.4
4.91
475
3154
(3022217) INR in Platelet poor plasma by Coagulation assay
94
355
3.02
18.72
13.7
15.6
inr
1.3
1.2
0.06
13
57
(3003694) ABO and Rh group [Type] in Blood
215
1232
2.30
17.93
1.6
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
469
3821
4.11
17.51
38.2
10.0
ml/min/173m2
92.8
90.4
1.35
439
3112
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
132
615
2.55
17.47
1.9
1.6
pmol/l
474.6
19815248.4
0.77
116
540
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
36
72
5.31
17.41
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
88
337
2.95
17.02
16.3
10.3
mmol/l
-0.7
1.1
3.36
72
272
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
17
14
12.53
16.99
2.6
1.4
umol/l
24.9
28.3
0.39
17
14
(3019309) Folate [Moles/volume] in Red Blood Cells
114
506
2.62
16.60
1.9
1.6
nmol/l
1186.5
1117.2
0.30
90
394
(3052851) Hemolysis interference index of Serum or Plasma
42
101
4.44
16.35
4.0
2.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
59
183
3.52
16.15
1.9
1.7
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
20
23
9.01
15.99
1.3
1.1
u/l
29.6
13.7
0.96
15
15
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
90
368
2.76
15.34
2.6
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
89
375
2.67
14.25
2.7
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
27
50
5.65
14.15
2.5
2.8
%
0.8
1.7
0.87
21
41
(1616796) Gas panel - Central venous blood
30
63
5.00
13.72
4.1
2.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
329
2385
2.08
13.62
5.2
3.6
e6/l
7.8
53.8
—
5
30
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
14
12
11.97
13.58
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
19
26
7.55
13.20
3.9
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
351
2624
2.10
13.14
5.2
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
98
463
2.38
12.23
2.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
35
6.22
12.22
3.8
2.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
48
157
3.27
12.05
1.9
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
98
3.88
11.88
2.2
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
172
1027
2.02
11.87
1.5
1.3
u/ml
1.5
1.8
0.26
40
272
(3000570) Elastase.pancreatic [Mass/mass] in Stool
36
99
3.84
11.72
1.6
1.4
ug/g
200.0
313.2
2.33
26
61
(3009542) Hematocrit [Volume Fraction] of Blood
469
4048
3.17
11.28
42.2
12.2
%
39.2
41.4
9.26
412
3293
(3033799) Differential panel - Peritoneal fluid
15
6
25.69
11.19
3.5
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
153
922
1.95
10.01
4.3
2.4
umol/l
1847.8
5496.7
1.05
144
830
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
20
7.17
9.33
1.1
1.0
miu/ml
1337.4
1483.5
0.21
14
20
(3012501) Base excess in Blood by calculation
25
63
4.12
9.16
4.3
2.3
mmol/l
1.9
2.8
1.06
16
43
(3015377) Calcium [Moles/volume] in Serum or Plasma
175
1130
1.84
9.11
4.8
3.1
mmol/l
2.3
2.4
2.17
166
1008
(40761536) Microorganisms panel - Urine sediment
70
323
2.35
9.10
3.8
2.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
145
883
1.90
9.07
2.7
2.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
25
64
4.06
8.97
4.6
2.2
%
15.1
17.1
1.57
15
34
(3035350) Ketones [Presence] in Urine by Test strip
257
1878
1.75
8.66
3.8
3.0
estimate
0.0
0.0
0.00
69
358
(40761511) CBC panel - Blood by Automated count
487
4411
3.77
8.48
34.0
10.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
256
1878
1.74
8.43
5.5
4.2
estimate
0.0
0.0
0.00
71
371
(3009261) Glucose [Presence] in Urine by Test strip
258
1903
1.73
8.28
3.9
3.0
estimate
0.0
0.0
0.50
72
351
(3003338) MCHC [Mass/volume]
437
3787
2.13
7.98
47.4
14.2
g/l
332.5
334.4
4.09
437
3766
(4281824)
16
31
5.30
7.97
1.3
1.1
—
—
—
0
0
(3015736) pH of Urine
209
1469
1.72
7.88
3.2
2.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
96
3.26
7.81
2.5
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
34
119
2.99
7.64
5.8
9.5
%
0.9
0.9
0.07
34
111
(3004588) Protein electrophoresis panel - Serum or Plasma
43
172
2.64
7.55
1.7
2.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
34
125
2.84
7.01
5.7
9.1
%
1.4
1.6
0.39
34
115
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
8
14.02
6.92
1.3
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
24
5.53
6.80
1.5
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
6
16.97
6.77
1.8
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
9
12.46
6.61
3.8
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
20
57
3.61
6.22
4.8
2.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
34
134
2.65
6.17
1.4
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
58
3.55
6.07
2.4
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
133
880
1.69
5.98
2.2
2.0
mg/l
1.9
1.0
2.22
111
656
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
452
4064
2.05
5.98
6.3
3.9
mmol/l
4.6
4.7
2.76
440
3835
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
69
3.29
5.94
1.8
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
69
3.29
5.94
1.8
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
52
254
2.17
5.90
3.8
3.7
kpa
5.0
5.1
0.56
47
244
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
180
1291
1.61
5.89
3.7
3.1
ng/l
32.0
47.5
0.46
114
763
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
43
194
2.33
5.88
1.6
1.5
—
—
—
0
0
(3019225) pH of Specimen
60
312
2.05
5.79
4.5
4.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
41
4.00
5.75
1.7
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
50
243
2.17
5.74
3.8
3.7
mmol/l
1.2
1.5
0.18
30
183
(3009343) pH of Capillary blood
51
253
2.13
5.57
3.8
3.6
ph
7.4
7.4
0.19
12
27
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
380
3272
1.65
5.51
3.6
3.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
123
816
1.67
5.42
3.2
3.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
33
138
2.49
5.33
1.2
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
8
11.42
5.31
1.2
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
9
8
11.42
5.31
4.1
2.9
%
51.8
52.3
—
9
8
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
89
546
1.76
5.19
4.8
2.8
mmol/l
2.5
2.4
0.69
82
482
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
99
639
1.68
4.80
4.2
3.4
ng/l
18.9
266.7
3.40
72
431
(3000093) Morphology [Interpretation] in Blood Narrative
12
30
4.07
4.46
1.3
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
55
3.16
4.40
1.9
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
35
3.79
4.39
2.2
1.3
pg
31.9
34.0
0.94
13
35
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
22
4.62
4.32
3.1
3.1
u/ml
4324.3
729.9
—
10
22
(3001186) Copper [Moles/volume] in Serum or Plasma
7
6
11.80
4.28
1.1
1.2
umol/l
17.6
15.6
—
7
6
(42529406) Shigella sp [Presence] in Stool by Culture
31
140
2.29
4.27
1.3
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
91
2.60
4.19
2.1
2.0
g/l
12.4
10.2
0.95
23
83
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
58
3.00
4.04
2.5
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
99
2.50
4.03
2.0
2.0
g/l
6.9
7.4
0.63
19
83
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
99
2.50
4.03
2.0
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
99
2.50
4.03
2.0
2.0
g/l
3.9
3.8
0.31
19
77
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
138
2.25
3.98
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
138
2.25
3.98
1.3
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
59
2.95
3.93
2.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
59
2.95
3.93
2.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
59
2.95
3.93
2.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
59
2.95
3.93
2.5
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
18
65
2.83
3.89
6.7
14.5
mmol/l
106.8
105.1
0.91
18
57
(3039000) Anion gap in Blood
18
65
2.83
3.89
6.7
14.5
mmol/l
12.3
11.1
0.80
18
57
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
60
2.90
3.83
2.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
149
1113
1.48
3.77
3.9
2.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
55
2.97
3.77
4.5
2.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
189
1483
1.44
3.69
4.1
3.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
19
73
2.67
3.68
2.1
3.7
mg/l
36.5
125.3
0.57
11
63
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
19
73
2.67
3.68
2.1
3.7
mg/l
30.0
30.6
0.04
11
62
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
40
3.31
3.65
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
40
3.31
3.65
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
9
7.87
3.57
1.3
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
11
31
3.61
3.50
2.7
2.6
mmol/l
3.9
4.1
0.39
11
31
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
31
3.61
3.50
2.7
2.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
11
31
3.61
3.50
2.7
2.6
mmol/l
104.1
105.3
0.34
11
31
(3029937) Albumin [Presence] in Urine by Test strip
133
988
1.47
3.42
4.3
3.2
estimate
0.0
0.0
0.50
68
355
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
71
2.59
3.33
1.3
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
19
4.80
3.25
1.4
1.2
ug/l
12.6
8.9
—
9
19
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
28
3.62
3.21
3.3
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
262
1.79
3.15
1.3
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
122
907
1.45
3.10
3.0
3.3
mg/l
54.6
294.3
1.10
80
602
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
33
175
1.95
3.08
1.2
1.3
miu/ml
236.2
264.4
0.13
12
85
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
7
12
5.90
3.03
2.3
1.8
u/l
19.7
14.8
—
7
12
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
107
779
1.47
3.03
2.4
3.0
ng/l
1179.3
801.4
0.51
94
638
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
21
4.34
3.00
2.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
21
4.34
3.00
2.1
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
127
957
1.44
3.00
4.0
4.0
mg/mmol
9.6
9.8
0.02
87
626
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
77
0.00
2.98
0.0
6.1
—
390.5
—
0
68
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
5
10.08
2.98
1.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
46
2.87
2.94
1.3
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
30
3.38
2.92
1.1
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
130
2.05
2.86
2.2
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
47
2.81
2.83
1.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
71
2.44
2.83
1.3
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
124
2.07
2.81
2.0
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
84
2.31
2.80
1.9
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
19
84
2.31
2.80
2.2
2.0
g/l
38.1
38.5
0.09
19
75
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
18
4.50
2.80
4.4
2.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
132
1014
1.41
2.79
2.2
1.6
mmol/l
1.3
1.4
1.81
125
873
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
20
91
2.25
2.77
2.1
2.2
g/l
0.0
1.0
2.09
20
85
(40760888) Immunoglobulin light chains.free panel - Serum
14
54
2.64
2.72
1.1
4.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
140
1.98
2.70
2.0
2.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
19
4.26
2.69
1.1
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
68
462
1.55
2.67
1.8
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
43
677
0.60
2.64
2.2
2.5
ug/l
0.8
0.7
0.17
22
370
(3038515) Glucose [Moles/volume] in Venous blood
14
55
2.59
2.63
5.9
3.1
mmol/l
7.8
7.6
0.13
14
55
(3003740) Influenza virus B Ag [Presence] in Specimen
21
100
2.15
2.62
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
21
100
2.15
2.62
1.1
1.1
—
—
—
0
0
(3013512) EKG study
124
952
1.40
2.61
3.6
3.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
87
2.23
2.60
1.9
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
11
38
2.94
2.59
1.7
2.6
%
63.5
62.6
—
6
28
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
44
2.77
2.56
2.2
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
7
7.20
2.55
3.6
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
33
3.07
2.54
2.0
2.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
26
3.50
2.49
2.3
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
26
3.50
2.49
1.2
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
7
16
4.42
2.48
1.3
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
45
2.71
2.46
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
21
103
2.08
2.45
2.0
2.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
8
6.30
2.37
1.0
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
17
4.16
2.36
1.1
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
143
1142
1.35
2.35
3.1
3.2
mmol/l
8.5
8.7
0.09
131
989
(3008898) HLA-B27 [Presence]
36
216
1.72
2.32
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
53
2.49
2.29
1.6
1.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
8
23
3.52
2.28
1.4
1.3
g/l
33.7
32.3
—
8
17
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
13
4.66
2.27
1.7
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
60
2.37
2.23
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
12
48
2.54
2.20
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
65
899
0.68
2.20
2.6
3.5
%
20.8
21.5
0.11
15
336
(3000492) Spirometry study
63
441
1.49
2.17
1.6
1.4
—
—
—
0
0
(4268621)
13
55
2.40
2.14
2.6
2.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
7
20
3.53
2.06
1.7
1.7
%
206.9
135.7
—
7
20
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
15
4.03
2.04
1.2
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
31
186
1.71
2.02
7.5
7.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
42
275
1.57
1.97
2.4
2.3
e9/l
4.4
4.2
0.22
30
231
(3028433) Virus identified in Specimen by Culture
7
21
3.36
1.97
1.1
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
21
3.36
1.97
2.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
21
3.36
1.97
2.0
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
11
4.58
1.94
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
45
2.48
1.94
2.2
2.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
16
3.78
1.94
1.2
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
39
2.60
1.93
1.7
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
22
3.21
1.88
1.3
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
40
2.53
1.84
1.7
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
12
4.20
1.82
3.8
4.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
80
2.03
1.82
6.1
4.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
35
2.60
1.81
2.1
6.5
%
7.7
12.1
—
9
35
(3011412) CD3 cells [#/volume] in Blood
11
47
2.37
1.79
2.0
2.1
e9/l
0.8
1.1
—
6
21
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
6
18
3.36
1.75
1.0
1.4
u/field
1.3
11.4
—
6
12
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
36
2.53
1.74
1.0
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
36
2.53
1.74
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
36
2.53
1.74
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
36
2.53
1.74
1.3
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
36
2.53
1.74
1.2
1.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
7
24
2.94
1.73
2.3
2.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
25
2.82
1.65
1.6
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
84
1.93
1.61
1.1
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
63
2.09
1.61
1.5
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
27
415
0.63
1.54
12.4
5.7
—
—
—
0
0
(44790049)
10
44
2.30
1.54
2.4
1.6
—
—
—
0
0
(44790048)
10
44
2.30
1.54
2.4
1.6
—
—
—
0
0
(44806118)
10
44
2.30
1.54
2.4
1.6
—
—
—
0
0
(44790047)
10
44
2.30
1.54
2.4
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
47
642
0.70
1.49
1.3
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
37
2.46
1.48
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
37
2.46
1.48
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
37
2.46
1.48
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
148
1722
0.80
1.47
3.9
2.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
326
0.60
1.46
2.1
2.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
22
2.75
1.44
1.7
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
29
2.43
1.39
1.7
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
82
1.85
1.37
5.3
3.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
47
2.15
1.34
1.1
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
42
2.16
1.34
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
24
2.52
1.30
1.5
1.4
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
18
2.79
1.29
1.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
35
2.31
1.27
1.6
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
49
367
1.37
1.23
1.3
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
19
2.65
1.22
1.6
1.8
ug/l
89.4
83.5
—
5
19
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
298
0.62
1.22
1.7
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
127
0.47
1.18
1.5
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
20
2.51
1.15
1.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
20
2.51
1.15
1.2
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
114
0.43
1.13
2.2
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
51
1.98
1.12
2.0
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
373
0.68
1.11
1.1
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
407
0.70
1.10
2.0
2.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
21
2.39
1.09
1.6
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
22
145
1.54
1.07
4.5
3.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
370
0.69
1.07
1.9
2.3
—
—
—
0
0
(1002224) Polysomnography panel
14
228
0.60
1.06
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
28
196
1.45
1.04
3.2
3.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.0
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.8
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.0
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
147
1.52
1.02
1.6
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
91
1.67
1.01
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
467
0.73
1.00
1.5
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
68
828
0.79
1.00
1.8
2.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
43
555
0.75
0.99
1.2
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
27
375
0.70
0.99
1.9
2.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
84
1.69
0.98
1.3
1.2
—
1.2
—
0
8
(3028707) Methadone [Presence] in Urine by Screen method
10
174
0.57
0.98
1.9
2.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
27
374
0.71
0.97
1.9
2.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
25
351
0.70
0.97
2.0
2.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
7
36
1.96
0.97
1.1
1.8
—
17.5
—
0
11
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
50
1.81
0.97
1.1
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
96
1121
0.82
0.96
2.7
3.8
ug/l
1.5
1.8
0.53
86
1028
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
61
745
0.79
0.93
1.8
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
27
368
0.72
0.90
1.9
2.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
25
178
1.43
0.88
1.5
1.6
u/l
4.7
7.6
1.52
16
148
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
17
112
1.54
0.86
1.4
1.2
—
3.4
—
0
13
(3019832) Treponema pallidum Ab [Presence] in Serum
49
606
0.79
0.84
1.8
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
48
1.68
0.79
1.7
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.1
—
1.1
—
0
14
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
100
0.50
0.78
1.0
1.3
mmol/l
3.3
3.7
—
5
93
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
318
3015
1.15
0.78
4.1
3.7
pmol/l
14.4
14.6
0.50
292
2772
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
405
3911
1.18
0.76
5.0
3.5
mmol/l
1.2
1.3
2.36
393
3676
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
67
1.66
0.75
1.1
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
55
1.65
0.74
1.9
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
418
4051
1.18
0.73
5.5
3.8
mmol/l
1.5
1.4
4.17
405
3811
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
84
1.56
0.72
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
19
134
1.43
0.72
1.4
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
7
41
1.72
0.70
2.0
1.2
pmol/l
809.0
403.9
—
7
34
(3042631) Mycobacterium sp identified in Specimen
7
42
1.68
0.68
3.1
2.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
119
0.58
0.68
1.0
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
43
1.64
0.67
8.3
2.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
39
314
1.26
0.66
1.1
1.3
iu/ml
89.1
155.5
—
10
129
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
372
3847
0.88
0.64
3.9
3.8
mmol/l
5.9
5.8
0.28
359
3572
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
87
1.51
0.64
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
422
4111
1.16
0.59
5.6
4.2
mmol/l
2.7
2.9
5.58
406
3851
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
7
112
0.62
0.58
1.0
1.4
mg/l
364.7
407.1
—
7
106
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.2
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
148
0.67
0.56
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
148
0.67
0.56
1.5
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
37
1.63
0.55
1.3
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
122
0.65
0.55
1.3
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
147
0.67
0.54
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
147
0.67
0.54
1.5
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
157
0.69
0.52
1.6
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
51
436
1.19
0.52
1.8
2.2
nmol/l
15.3
14.1
0.45
45
401
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
258
0.77
0.51
1.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
68
1.48
0.47
1.0
1.2
u/l
29.9
11.2
—
10
62
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
81
0.61
0.46
1.4
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
138
1.32
0.46
1.3
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
22
275
0.79
0.46
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.0
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
129
0.69
0.44
1.6
1.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
87
1.39
0.42
1.2
1.1
—
11.5
—
0
7
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
374
3642
1.10
0.42
4.6
4.3
mu/l
2.0
2.1
0.25
352
3395
(40768795) Lymph node Pathology biopsy report
5
33
1.52
0.41
2.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.2
—
17.8
—
0
15
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.7
—
—
—
0
0
(3017704) Immunofixation for Urine
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
80
878
0.89
0.38
4.7
3.1
kg/l
1.0
1.0
0.04
15
109
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
36
1.39
0.38
6.8
4.1
—
56.6
—
0
10
(3050129) First trimester maternal screen panel - Serum or Plasma
14
179
0.78
0.36
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
121
0.74
0.35
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
124
0.72
0.35
1.4
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
1.2
1.2
nmol/l
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.0
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
144
0.76
0.33
1.9
1.7
—
—
—
0
0
(4010399)
23
274
0.83
0.33
1.3
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
11
83
1.33
0.32
2.9
2.4
ug/min
60.7
74.8
—
6
52
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
49
440
1.13
0.30
3.0
3.9
%
36.4
30.6
3.21
43
307
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
110
0.72
0.29
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
120
0.75
0.27
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
150
0.80
0.27
2.1
2.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
76
1.19
0.24
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
82
0.73
0.24
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
95
0.73
0.22
2.9
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
220
1.14
0.21
3.8
2.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4015189)
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
102
0.78
0.21
1.5
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.1
—
0.8
—
0
7
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
23.4
—
0
13
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
79.9
—
0
13
(3011288) Drugs identified in Urine by Screen method
23
261
0.88
0.21
2.3
3.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
353
3588
0.95
0.20
6.3
4.8
mmol/mol
37.7
38.8
1.35
341
3394
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
202
1.15
0.20
2.3
2.6
u/l
2364.3
3124.2
—
8
86
(40768800) Prostate Pathology biopsy report
6
50
1.20
0.19
1.0
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
24
268
0.89
0.17
2.6
3.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
7
61
1.15
0.17
1.4
1.3
ug/l
3.0
3.3
—
7
53
(3037121) Protein [Mass/volume] in Urine
15
129
1.17
0.17
1.9
3.5
g/l
0.2
0.2
—
10
59
(4306422)
8
69
1.16
0.16
1.4
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
69
1.16
0.16
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
14
120
1.17
0.16
9.4
4.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
214
1.08
0.08
2.1
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
65
673
0.96
0.08
1.3
1.3
u/ml
1.4
9.9
3.81
25
272
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
60
0.83
0.08
1.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
64
1.10
0.08
4.6
2.1
%
13.3
13.0
—
7
64
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
66
1.06
0.08
1.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
90
0.89
0.07
1.0
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
104
0.86
0.06
2.4
2.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
151
0.93
0.05
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
104
1027
1.02
0.03
1.6
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
63
641
0.98
0.02
1.5
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
69
701
0.98
0.02
1.3
1.3
iu/ml
18.3
28.0
0.90
24
223
(3001019) Free T4 and TSH panel - Serum or Plasma
27
261
1.04
0.02
1.4
1.6
—
—
—
0
0
(4034850)
12
124
0.97
0.00
9.8
8.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
243
0.99
0.00
1.0
1.2
—
—
—
0
0
(4094501)
11
108
1.02
0.00
1.2
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
5.8
—
0
8
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
82
0.98
0.00
1.4
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
600
1.00
0.00
1.5
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
5
0.00
0.00
0.0
2.6
—
74.8
—
0
5
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
69
0.87
0.00
1.2
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
6.4
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
7
0.00
0.00
0.0
3.0
—
4.6
—
0
7
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
60
1.00
0.00
1.5
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
65
0.92
0.00
1.3
1.1
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
65.2
—
0
5
(3014051) Protein [Presence] in Urine by Test strip
6
66
0.91
0.00
1.3
1.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
11.3
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.4
—
52.7
—
0
7
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
2.1
—
0
8
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: K11_PSC_COLITIS – Colitis, primary sclerosing

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).